Board of Directors

Frederick Bart 

Non-Executive Chair

In 1985, Mr Bart was appointed the Managing Director of Textile Industries Australia The Group employed over 1,200 people and distributed product to many countries worldwide. The Company manufactured and distributed the majority of bed linen in Australia under brands like Sheridan and ACTIL The Company was sold in 1987.

In 1989, Mr Bart established and chairs a number of private companies under the umbrella of the Bart Group which covered hotels, retail, commercial and residential land development and technologies which still continue to operate. The Group today employs in excess of 1,000 people and is active in many local and overseas markets.

In 2001, Mr Bart became Chairman of Electro Optic Systems Holdings Limited (ASX: EOS). Since that time it has grown to be one of Australia’s premier defence companies with activities in many countries worldwide employing over 400 people and is currently included in the S&P/ASX 300.

In September 2000, Mr Bart became a director and Chairman of Audio Pixels Holdings Limited (ASX: AKP). Audio Pixels is developing the first digital speaker in the world and currently has a market capitalisation of over $600m.

In 2013, Mr Bart became Chairman and majority shareholder of Immunovative Therapies Limited, a private Israeli company involved in the manufacture of vaccines for the treatment of certain forms of cancer. The Company has undertaken trials in both collateral and liver cancers.

In March 2018, Mr Bart joined the Board of Weebit Nano Limited (ASX: WBT). Weebit is a developer of memory technology (1,000 X faster, 1,000 X more energy efficient and 100X higher endurance) than existing flash memory technologies.

In May 2020, Mr Bart was appointed to the Board of Noxopharm Limited (ASX: NOX).

Read more
Gisela Mautner

Dr Gisela Mautner 

Chief Executive Officer and Managing Director

MD-PhD (TU-LMU Munich), MPH (Harvard), MBA (Kellogg), FACPE (Australia), GAICD

Dr Gisela Mautner has more than 20 years of extensive leadership experience in global pharmaceutical organisations, including operational, medical and scientific advisory roles across multiple therapeutic areas. During her career she held senior positions at global pharmaceutical companies like MSD (Merck), Bayer and Amgen in Germany as well as Australia.

She holds a Doctor of Medicine degree and a PhD from Germany, a Master of Public Health (MPH) from Harvard University, and a Master of Business Administration (MBA) from Northwestern University of Chicago.

She is a Graduate of the Australian Institute of Company Directors (GAICD).

Gisela was appointed Chief Executive Officer and Managing Director of Noxopharm in 2022, previously serving as Chief Medical Officer since 2019.

Read more
Peter Marks

Peter Marks 

Non-Executive Director and Deputy Chairman

B.Econ; LL.B; Grad Dip. Comm.Law;  (all Monash Univ.) MBA (Scottish Business School, Edinburgh)

Mr Peter Marks has over 35 years’ experience in corporate advisory and investment banking. Over the course of his career, he has specialised in capital raising IPO's, cross border capital raisings, M&A transactions, corporate underwriting and venture capital transactions for companies based in Australia, the US and Israel. He has been involved in a broad range of transactions with a special focus in the life-sciences, biotechnology, medical technology and high tech as well as the mining sector. Peter has served as both an Executive and Non-Executive Director of a number of different entities, many of which have been listed on the ASX, Nasdaq and AIM markets.

Peter currently holds Board positions with the following listed entities -Alterity Therapeutics Limited (ASX: ATH), Iris Metals Ltd (ASX:IR1) and Evergreen Lithium Ltd (EG1), and is a former Board member of Fluence Corporation Limited (ASX: FLC), Elsight Limited (ASX: ELS) and Nyrada Inc. (ASX:NYR). He is also a Board member of unlisted hydrogen company, Electriq Global Ltd. He also sits and has sat on the Audit and Remuneration Committees for several of the abovementioned companies.

Peter holds a Bachelor of Economics, a Bachelor of Law and a Graduate Diploma in Commercial Law from Monash University, Australia. He also holds an MBA from the University of Edinburgh, Scotland.

Read more
Boris Patkin

Boris Patkin 

Non-Executive Director

BSc (Industrial Chem) MeSAFAA

Mr Boris Patkin brings comprehensive market knowledge, thorough research and years of experience in investment markets and business consulting.

As a financial and investment advisor, Boris has an in-depth understanding of industry trends and has valuable insight into domestic and international markets. He specialises in the reconstruction of companies, investments and in international trade and is also an experienced business consultant in the medical and disruptive technology arena.

Boris has a Bachelor of Science (Industrial Chemistry) from UNSW. He is currently a member of MeSAFAA and is a Senior Advisor with Morgans Financial Ltd.

Read more
David Franks

David Franks 

Company Secretary

B.Ec ( Finance and Accounting)

David is a Director and Principal of the Automic Group. He is a Chartered Accountant, Fellow of the Financial Services Institute of Australasia, Fellow of the Governance Institute of Australia, Justice of the Peace and Registered Tax Agent.

 With over 25 years’ experience as a Director and Company Secretary of numerous unlisted and publicly listed entities, David has been involved in a range of industries including energy retailing, transport, financial services, mineral and oil & gas exploration, technology, automotive, software development and commercialisation and healthcare

David is currently the Company Secretary for Applyflow Limited, COG Financial Services Limited, Cogstate Limited, Dubber Corporation Limited, Evergreen Lithium Limited, Exopharm Limited, GB Energy Holdings Limited, IRIS Metals Limited, IXUP Limited, JCurve Solutions Limited, Noxopharm Limited, Nyrada Inc, Omega Oil & Gas Limited, Superhero Holdings Limited, White Energy Company Limited and Zip Co Limited.

He holds a Bachelor of Economics (Finance and Accounting) from Macquarie University and is a Fellow of the Governance Institute of Australia.

Read more